50 pro-life leaders call on FDA nominee Dr. Heidi Overton to restore 'minimal safeguards' on mifepristone
Dr. Heidi Overton has been nominated to lead the FDA. A group of 50 pro-life leaders has called on her to restore earlier safety restrictions on mifepristone, an abortion drug, while the FDA completes an ongoing safety review. At least one reproductive rights advocate has disputed whether her approach aligns with scientific evidence on the drug's safety.
3 across the spectrum · tap a section to jump
The story so far
2 developments- Sep 2450 pro-life leaders call on FDA nominee Dr. Heidi Overton to restore 'minimal safeguards' on mifepristone
- Sep 25Opinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drug
Who covered each development
No new developments
Quiet for 4 daysLast development · Sep 25 — Opinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drug
Left
0 viewpointsNo Left coverage yet.
A blind spot on this side of the story.
Center
1 viewpointOpinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drug
Right
2 viewpoints50 pro-life leaders call on FDA nominee Dr. Heidi Overton to restore 'minimal safeguards' on mifepristone
50 Pro-Life Leaders Urge FDA to End Biden’s Mail-Order Abortion Scheme Ahead of Commissioner Confirmation Hearing